Granite Investment Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,135
Closed -$349K 323
2017
Q4
$349K Sell
2,135
-6,370
-75% -$1.14M 0.02% 280
2017
Q3
$1.74M Sell
8,505
-10,072
-54% -$2.34M 0.11% 154
2017
Q2
$4.52M Sell
18,577
-13,935
-43% -$3.27M 0.3% 104
2017
Q1
$7.77M Buy
32,512
+2,522
+8% +$587K 0.53% 84
2016
Q4
$6.3M Sell
29,990
-14,047
-32% -$2.91M 0.46% 87
2016
Q3
$10.1M Buy
44,037
+5,461
+14% +$1.33M 0.76% 36
2016
Q2
$8.91M Buy
38,576
+8,655
+29% +$2M 0.7% 47
2016
Q1
$8.02M Buy
29,921
+2,202
+8% +$630K 0.73% 41
2015
Q4
$8.66M Buy
27,719
+5,868
+27% +$1.75M 0.78% 35
2015
Q3
$5.94M Buy
21,851
+158
+0.7% +$48.5K 0.57% 71
2015
Q2
$6.58M Buy
21,693
+1,050
+5% +$313K 0.61% 58
2015
Q1
$6.14M Buy
+20,643
New +$5.89M 0.53% 78

Other funds holding AGN

Granite Investment Partners's AGN Position: Q1 2018 in Review

Granite Investment Partners sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,135 shares — an estimated $349K sold.

Granite Investment Partners first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $10.1M in Q3 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Granite Investment Partners reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Granite Investment Partners sold 2,135 Allergan plc shares in Q1 2018, an estimated $349K.
  • Granite Investment Partners first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • Granite Investment Partners's Allergan plc position peaked at $10.1M in Q3 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Granite Investment Partners's 13F filing for Q1 2018, filed 4 May 2018.